Fletcher-Flora develops and distributes a full line of Laboratory Information System (LIS) products dedicated to solving the day-to-day problems of the clinical laboratory.  With over 20 years developing LIS systems, it has become a rapidly growing LIS company in the physician office lab marketplace, and a leader in Electronic Medical Records and Practice Management interfaces.  Fletcher-Flora has grown from having 80 systems installed in 1996 to over 1200 total installed systems by year end 2004.  Of these over 250 of these installations are in hospital accounts and the balance in Physician Office laboratories, Group practices and Reference laboratories. 2004 unaudited annual revenues were approximately $5,000,000.00

According to Fletcher-Flora's President, Neal Flora, "Fletcher-Flora is a dynamic laboratory software company that has successfully marketed its LabPak® product line for nearly a decade.  During that time, Fletcher-Flora has become one of the unit placement leaders in the Physicians Office Laboratory (POL) market and has achieved the number one position ranking in total customer account placements in the POL market for 2004, as researched and ranked in the R.L. Johnson Annual LIS Report, a recognized and respected independent LIS expert and information resource.  Moreover, while not currently targeting the hospital laboratory market directly, Fletcher-Flora has achieved the number four ranking in hospital customer placements according to the same R.L. Johnson LIS report for 2004. Therefore with the acquisition of the larger hospital technology, Fletcher-Flora is prepared to expand its business and market position as a health care software company equipped to service and be competitive in the overall hospital based marketplace"

About Fletcher-Flora

For more than 20 years, Fletcher-Flora has developed and marketed Laboratory Information Systems for physician offices and hospital laboratories. Physicians in private practice, group practices and hospitals regularly order laboratory tests on various samples to make a diagnosis or monitor patients. Typically these test are run on instruments that take the sample, add reagents and then quantify and report the results to the physician. Effective management of this data is essential for the efficiency and profitability of the laboratory. Fletcher-Flora has grown to become a leader in both the non-hospital market and hospital market.

Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on CFI's expectations and are subject to a number of risks and uncertainties beyond CFI's control, including but not limited to economic, competitive and other factors affecting CFI's operations, management team effectiveness, expansion strategies, available financing, market prices and recovery costs, government regulations involving CFI, facts and events not known at the time of this release.

These statements are not guarantees of future performance and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. CFI undertakes no obligation to update publicly any forward-looking statements.